Author
S. Jha
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2024 · peak 5/yrCo-Author Collaboration Network
10 top collaborators · 21 mutual co-author links14 papers
Recent·Most cited
Oryza genera-specific novel Histone H4 variant predisposes H4 Lysine5 Acetylation marks to modulate salt stress responses
V. H. S. G, P. Sotelo-Parrilla, S. Raju, S. Jha, A. Gireesh, F. Gut, V. R. Kutti, F. Berger, A. A. Jeyaprakash, P. V. Shivaprasad
The paper identifies a novel histone H4 variant in Oryza that modulates salt stress responses through chromatin remodeling and acetylation marks.
bioRxiv · Jul 31, 2023 · PreprintPlant Biology
The alphavirus TF protein plays a critical role in promoting viral propagation by altering cell-cell boundaries
P. Tatiya, R. Kumar, D. Dey, Y. Ratra, S. Y. Mian, S. Borkotoky, S. Jha, Bhawna, S. Arora, K. Suhag, S. Basak, M. Banerjee
This paper identifies the alphavirus TF protein's role in promoting viral propagation by altering cell-cell boundaries through downregulation of Scribble.
bioRxiv · Jul 24, 2023 · PreprintCell Biology
Detergent induced structural perturbations in peanut agglutinin: Insights from spectroscopic and molecular dynamic simulation studies
S. Asthana, S. Mohanty, H. Kalra, N. Karunanethi, S. Kumar, N. Agrawal, S. Jha
This study investigates how SDS and CTAB detergents affect the structure of peanut agglutinin using spectroscopic and molecular dynamics simulations, revealing structural perturbations and conformational changes.
bioRxiv · Jul 3, 2023Biochemistry
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity and neutralization sensitivity
S. Kumar, R. Delipan, D. Chakraborty, K. Kanjo, R. Singh, N. Singh, S. Siddiqui, A. Tyagi, S. Jha, K. G. Thakur, R. Pandey, R. Varadarajan, R. P. Ringe
This study investigates how mutations in the S2 subunit of SARS-CoV-2 Omicron spike affect its structure, fusogenicity, and neutralization sensitivity.
bioRxiv · Mar 5, 2023Microbiology
E4F1 and ZNF148 are transcriptional activators of the A57C and wildtype TERT promoter
B. H. Chua, L. Ferry, C. Domrane, N. Zaal Anuar, A. Wittek, S. Jha, F. Butter, D. G. Tenen, P.-A. Defossez, D. Kappei
The paper identifies E4F1 and ZNF148 as transcriptional activators of the A57C and wildtype TERT promoter, respectively, and shows their role in upregulating TERT transcription and telomerase activity.
bioRxiv · Jan 13, 2023Cancer Biology
Adaptive Ensemble Refinement of Protein Structures in High Resolution Electron Microscopy Density Maps with Radical Augmented Molecular Dynamics Flexible Fitting
D. Sarkar, H. Lee, J. W. Vant, M. Turilli, J. V. Vermaas, S. Jha, A. Singharoy
This paper introduces an adaptive ensemble refinement method for protein structures using MDFF and RADICAL-Cybertools, improving correlation with cryo-EM density maps by 40%.
bioRxiv · Dec 7, 2021 · PreprintBiophysics
In vitro reconstitution demonstrates the amyloid-beta mediated myelin membrane deformation
M. Saleem, A. Tiwari, S. Pradhan, A. Sannigrahi, S. Jha, K. Chattopadhyay, M. Biswas
This study shows A{beta}-40 induces myelin membrane tubulation in vitro through binding and aggregation, revealing mechanisms of potential neuronal demyelination in Alzheimer's Disease.
bioRxiv · Aug 13, 2021 · PreprintBiophysics
Integrative Epigenomic and High-Throughput Functional Enhancer Profiling Reveals Determinants of Enhancer Heterogeneity in Gastric Cancer
T. Sheng, S. W. T. Ho, W. F. Ooi, C. Xu, M. Xing, N. Padmanabhan, K. K. Huang, L. Ma, M. Ray, Y. A. Guo, S. N. Leng, C. G. Anene-Nzelu, M. M. Chang, M. Razavi-Mohseni, M. Beer, , P. Tan
The paper identifies enhancer heterogeneity in gastric cancer by integrating epigenomic data and functional assays, linking it to genetic and regulatory factors.
bioRxiv · Jun 9, 2021Cancer Biology
High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent Inhibitor
A. Clyde, S. Galanie, D. W. Kneller, H. Ma, Y. Babuji, B. Blaiszik, A. Brace, T. Brettin, K. Chard, R. Chard, L. Coates, I. Foster, D. Hauner, V. Kertesz, N. Kumar, , R. Stevens
This paper identifies a novel non-covalent inhibitor of SARS-CoV-2 main protease through high throughput virtual screening, validated by biochemical assays, X-ray crystallography, and molecular dynamics simulations.
bioRxiv · Mar 27, 2021 · PreprintBiophysics
Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative
S. K. Malladi, U. R. Patel, R. S. Rajmani, R. Singh, S. Pandey, S. Kumar, S. Khaleeq, P. J. v. Vuren, S. S. Riddell, S. Goldie, S. Gayathri, D. Chakraborty, P. Kalita, I. Pramanick, N. Agarwal, , R. Varadarajan
This study designs a thermotolerant trimeric RBD vaccine candidate that elicits strong neutralizing antibodies against multiple SARS-CoV-2 variants in animal models.
bioRxiv · Jan 13, 2021Microbiology
AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics
L. Casalino, A. C. Dommer, Z. Gaieb, E. P. Barros, T. Sztain, S.-H. Ahn, A. Trifan, A. Brace, H. Ma, H. Lee, M. Turilli, A. Bogetti, S. Khalid, L. Chong, C. Simmerling, , R. E. Amaro
This paper develops an AI-driven workflow to simulate SARS-CoV-2 spike protein dynamics, revealing glycan shield structure, spike glycans' role in infectivity, and spike-ACE2 interactions.
bioRxiv · Nov 19, 2020Biophysics
The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and metastasis-related processes through ZEB1/2
K. K. Lee, D. Rajagopalan, S. S. Bhatia, W. J. Chng, S. Jha
This study shows TRIP12 suppresses EMT and metastasis by inhibiting ZEB1/2 in breast cancer, based on patient data and cell experiments.
bioRxiv · Nov 4, 2020Cancer Biology
Boosting with ALVAC-HIV and AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity
D. Easterhoff, J. Pollara, K. Luo, W. D. Tolbert, B. Young, D. Mielke, S. Jha, R. J. O'Connell, S. Vasan, J. Kim, N. Michael, J.-L. Excler, M. L. Robb, S. Rerks-Ngarm, J. Kaewkungwal, , G. Ferrari
The paper shows that boosting RV144 vaccine recipients with ALVAC-HIV and AIDSVAX B/E increases C1C2-specific antibody-dependent cellular cytotoxicity breadth and potency.
bioRxiv · May 9, 2019 · PreprintImmunology